Company intelligence / Profile preview

Insight Lifetech

Shenzhen, Guangdong, Chinainsight-med.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

Insight Lifetech has developed several innovative medical devices for precision diagnosis and interventional therapy in cardiovascular medicine. Their first-generation FFR system has completed clinical trials and received both CE Marking and NMPA registration. The company’s IVUS system was selected as a National Key R&D Program in China. They continue to expand their portfolio with new catheter-based technologies targeting coronary interventions.

Therapeutic areas: Cardiovascular
Modalities: DeviceMedical imaging technologyDiagnostic deviceInterventional device
Industry: Medical Imaging

Beyond the preview

Go deeper on Insight Lifetech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insight Lifetech.

Explore the full profile